CONMED Corporation - Common Stock (CNMD)
42.41
+3.93 (10.21%)
NYSE· Last Trade: Jul 13th, 7:45 PM EDT
What Happened? Shares of medical tech company CONMED (NYSE:CNMD) jumped 9% in the afternoon session after reports revealed the company is exploring a potenti...
Via StockStory · July 13, 2026
Get insights into the top gainers and losers of Friday's after-hours session.chartmill.com
Via Chartmill · July 10, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via StockStory · July 9, 2026
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...
Via StockStory · July 6, 2026
CONMED Corporation (NYSE:CNMD) Beats Q1 Estimates and Raises Revenue Guidance, Shares Steadychartmill.com
Via Chartmill · April 29, 2026
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Via StockStory · July 3, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · June 30, 2026
What Happened? Shares of medical tech company CONMED (NYSE:CNMD) fell 4.9% in the afternoon session after BofA Securities downgraded the stock to Underperfor...
Via StockStory · June 29, 2026
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via StockStory · June 10, 2026
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - diversified stocks, including CONMED (NYSE:CNMD)...
Via StockStory · June 1, 2026
CONMED’s first quarter results were shaped by the company’s strategic exit from its gastroenterology (GI) product lines, which reduced reported sales but all...
Via StockStory · May 6, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via StockStory · May 6, 2026
Conmed (CNMD) Q1 2026 Earnings Transcript
Via The Motley Fool · April 30, 2026
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 1.3% year on year to $317 m...
Via StockStory · April 30, 2026
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 1.3% year on year to $317 mi...
Via StockStory · April 29, 2026
Medical tech company CONMED (NYSE:CNMD) will be reporting earnings this Wednesday after the bell. Here’s what you need to know. CONMED beat analysts’ revenue...
Via StockStory · April 27, 2026
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, incl...
Via StockStory · April 9, 2026
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via StockStory · April 6, 2026
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via StockStory · March 27, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via StockStory · March 26, 2026
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Via StockStory · March 20, 2026
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...
Via StockStory · March 10, 2026
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
Via StockStory · March 6, 2026
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Via StockStory · February 26, 2026
Over the past six months, CONMED’s shares (currently trading at $45.91) have posted a disappointing 15.7% loss, well below the S&P 500’s 7.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · February 26, 2026